Showing results (41-50 of 101) with videos related to

Sort By:
Pageof 11
Journal of Pediatric Hematology/Oncology|July 26, 2018
Sirolimus Treatment of an Infant With Intrathoracic Kaposiform Hemangioendothelioma Complicated by Life-threatening Pleural and Pericardial EffusionsLucy Duan, Samuele Renzi, Danielle Weidman, et al.
Seminars in Thrombosis and Hemostasis|August 25, 2016
Developing the First Recombinant Factor XIII for Congenital Factor XIII Deficiency: Clinical Challenges and SuccessesManuel Carcao, Katsuyuki Fukutake, Aida Inbal, et al.
Therapeutic Advances in Hematology|February 19, 2024
The effectiveness and safety of octocog alfa in patients with hemophilia A: up to 7-year follow-up of the real-world AHEAD international studyMargareth C Ozelo, Cedric Hermans, Manuel Carcao, et al.
Prenatal Diagnosis|March 20, 2021
Fetal therapy using rapamycin for a rapidly enlarging, obstructive, cervical lymphatic malformation: a case reportJoel Livingston, Nouf Alrowaily, Philip John, et al.
Journal of Pediatric Hematology/Oncology|December 14, 2004
Lymphomatous involvement of the heart in children: two cases and a review of the literaturePrabodh K Das, Ronald Grant, David Malkin, et al.
Research and Practice in Thrombosis and Haemostasis|September 2, 2025
Factor XIII deficiency due to compound heterozygosity for 2 <i>F13A1</i> variantsJodie Odame, Caroline Malcolmson, Cindy Wakefield, et al.
Research and Practice in Thrombosis and Haemostasis|March 22, 2024
Nonacog beta pegol prophylaxis in children with hemophilia B: safety, efficacy, and neurodevelopmental outcomes for up to 8 yearsKarin S Walsh, Christine Mrakotsky, Manuel Carcao, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 30, 2019
The changing face of immune tolerance induction in haemophilia A with the advent of emicizumabManuel Carcao, Carmen Escuriola-Ettingshausen, Elena Santagostino, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 23, 2019
Measuring the impact of changing from standard half-life (SHL) to extended half-life (EHL) FVIII prophylaxis on health-related quality of life (HRQoL) in boys with moderate/severe haemophilia A: Lessons learned with the CHO-KLAT toolManuel Carcao, Laura Zunino, Nancy L Young, et al.
Research and Practice in Thrombosis and Haemostasis|October 3, 2022
Thromboelastography and thrombin generation assessments for pediatric severe hemophilia A patients are highly variable and not predictive of clinical phenotypesNatalie Mathews, Fred G Pluthero, Margaret L Rand, et al.
Pageof 11